导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -7.39% | 137/240 |
| 近一周 | -1.71% | 55/246 |
| 近一月 | -1.19% | 52/246 |
| 近一季 | 0.20% | 82/246 |
| 近半年 | -5.57% | 140/242 |
| 近一年 | -11.72% | 113/235 |
| 近两年 | 35.88% | 95/204 |
| 近三年 | 33.57% | 66/162 |
| 成立以来 | -1.52% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.70% 188/360 |
-8.72% 259/366 |
- - |
- - |
| 2025 | 23.26% 85/358 |
16.14% 90/340 |
2.04% 213/348 |
10.91% 141/354 |
-6.23% 224/358 |
| 2024 | 27.39% 27/329 |
0.39% 166/280 |
9.13% 30/310 |
20.02% 83/318 |
-3.11% 197/329 |
| 2023 | -12.16% 172/275 |
2.83% 87/205 |
-6.91% 182/230 |
-4.92% 157/262 |
-3.48% 218/276 |
| 2022 | -16.87% 76/201 |
-8.54% 61/153 |
2.18% 60/164 |
-21.02% 125/189 |
12.63% 76/202 |
| 2021 | -21.11% 83/150 |
1.74% 146/312 |
-1.66% 272/328 |
-16.67% 286/358 |
-5.39% 78/151 |
| 2020 | -1.66% 57/103 |
-13.53% 169/280 |
3.07% 260/295 |
-2.35% 223/299 |
13.01% 74/305 |
| 2019 | 11.45% 65/88 |
10.65% 110/258 |
-2.22% 219/268 |
-5.63% 228/253 |
9.16% 85/266 |
| 2018 | -10.12% 49/79 |
- - |
- - |
- - |
-7.78% 91/241 |
| 2017 | 24.09% 17/69 |
- - |
- - |
- - |
- - |
| 2016 | -2.08% 40/59 |
- - |
- - |
- - |
- - |
| 2015 | -19.44% 37/49 |
- - |
- - |
- - |
- - |
| 2014 | 12.28% 20/99 |
- - |
- - |
- - |
- - |
| 2013 | -3.97% 51/70 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2946 | 31.47% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3488 | 29.79% |
| 汇添富恒生生物科技ETF(QDII) | 1.1245 | 29.24% |
| 南方恒生生物科技ETF(QDII) | 1.1400 | 29.08% |
| 广发道琼斯石油指数美元现汇A | 0.4638 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4557 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4568 | 27.33% |
| 南方恒生生物科技ETF发起联接(QDII)A | 1.2646 | 27.30% |
| 华夏恒生生物科技ETF发起式联接(QDII)C | 1.1472 | 27.25% |
| 汇添富恒生生物科技ETF发起式联接(QDII)C | 1.6358 | 27.22% |
| 易方达恒生国企ETF联接现汇A VS. 建信富时100指数(QDII)人民币A(539003) |